Member Info for PremierTrading35

Blimey, popped in to see what’s happening to find the usual...

It seems like some people’s emotions are directly linked to this share price. Up and they’re up, down and they’re down. I can not fathom the inability to take a step back to see this company being built before our eyes. Most of us have waited long enough that another couple of months surely isn’t too difficult to wait for, the evidence is all there! If you want to make money everyday, get a job or try day trading. If you want to make your money grow by doing nothing, then hold, and do nothing! So so simple IMO.

Have a nice day all!

Sell / Hold / Buy / Strong Buy / Throw the kitchen sink at it

Hmm...???

Lol

IMO DYOR

Well said FigTreeHarry!!

https://twitter.com/omegadiagnostic/status/1329409148165951490?s=21

...in 2021!!

Prosecco

Reference noticing Matt Han**** reaction to AZN approval by end of year, you were quite right.

This is the link to see the Cheshire Cat for yourselves, watch the full interview or fast forward to 20m 15seconds> ....

https://youtu.be/by86xy2FNUA

Reinforcing the IPO is to scale up ABC-19 Test

MUST WATCH! (4 mins)

https://www.proactiveinvestors.co.uk/companies/news/936984/abingdon-health-make-london-listing-debut-to--support-and-accelerate-growth-strategy--936984.html

DubleD - still a ****

Symbo1

An interesting theory!! Got me thinking...

Worst case valuation would be that there has been confirmation that a 3 billion order for vaccine doses is in place. The Abc19 test is our lowest profit margin test. If we used full capacity in April of 2 million PER WEEK (potentially 2.5mil as announced by CK) at 75 pence PROFIT, (again, Colin has said that this will be slightly more), just for this, our lowest profit margin test (any other test we produce would yield more profit) then we are looking at:

.75 x 2,000,000 = £1.5million per week PROFIT

1.5 x 50weeks (allowing 2 weeks Xmas shutdown maybe)

= £75,000,000 PROFIT P/A.

That is worst case scenario. Given the Antigen, CD4 etc with higher margins then this figure will only improve. So we currently have an MCAP of circa 75% of 2021’s profit (not revenue) as we stand, with an absolutely WORST CASE scenario.

2 Million Capacity will be achieved in April

MCAP £862.5m = £4.81 Per Share
MCAP £1380m = £7.70 Per Share

Merchantbanker
Posted in: ODX
Posts: 1,625
Price: 101.50
No Opinion
RE: Dear finnCap, here’s a real forecast for Omega08 Oct 2020 14:03
Here's a baseline valuation i posted a while back an extract of a few scenarios based on hitting the max 2m capacity. Replace the 2m test with your own number what you think they can make per week to give your own valuation. And BTW Food and CD4 are low end figures.

2m tests per week x 52 weeks x £3 average selling price = £312m revenues per year.
Add revenues from Food Tolerance and CD4 Total Revenues of circa £350m
Average margin of circa 55% = £192.5m gross profit
Admin expenses = Assume £20m. Net profit = £172.5m
Earnings multiplier x 5 = £862.5m
Earnings multiplier x 8 = £1,380m.

Cannabis laws lifted, any stigma reduced, brand acknowledgment, increased sales, increased MCAP/SP. Happy Investors!! ;-)

IMHO DYOR

This is the interview...

https://twitter.com/marcdicks/status/1265568844644524132?s=21

PremierTrading35
Posts: 79
Price: 109.50
No Opinion
RE: this orderToday 11:53
I did post this yesterday but think it may have been lost in the negative noise at the time.

“Okehurst

Regarding your questioning on g/p margin on tests, I remember Colin saying in his first presentation earlier this year that he would “expect the tests to be sold to the government for under £10”. I distinctly remember this and thinking at the time - WOW!! Not under £9, not under £8... etc. We now know that this has changed for the UK government but I feel that for anyone else this sort of price would be bare minimum.

Hopefully all we be revealed soon and Fincapp and Sharebuyers will need to bring out their biggest calculators for a much more accurate valuation”

I’m sure some of the LTH’s will remember this interview.

GLA DYOR

I did post this yesterday but think it may have been lost in the negative noise at the time.

“Okehurst

Regarding your questioning on g/p margin on tests, I remember Colin saying in his first presentation earlier this year that he would “expect the tests to be sold to the government for under £10”. I distinctly remember this and thinking at the time - WOW!! Not under £9, not under £8... etc. We now know that this has changed for the UK government but I feel that for anyone else this sort of price would be bare minimum.

Hopefully all we be revealed soon and Fincapp and Sharebuyers will need to bring out their biggest calculators for a much more accurate valuation”

I’m sure some of the LTH’s will remember this interview.

GLA DYOR

Okehurst

Regarding your questioning on g/p margin on tests, I remember Colin saying in his first presentation earlier this year that he would “expect the tests to be sold to the government for under £10”. I distinctly remember this and thinking at the time - WOW!! Not under £9, not under £8... etc. We now know that this has changed for the UK government but I feel that for anyone else this sort of price would be bare minimum.

Hopefully all we be revealed soon and Fincapp and Sharebuyers will need to bring out their biggest calculators!!

GLA DYOR

Bluemoon, did you notice the shelf life on all of these test, varying between 12-60 months.

Visitect 24 months!! Very interesting..!!! ;-)

DYOR

For those that are interested in product information:

http://www.elisa.co.uk/Portals/0/14266-CD4-BROCHURE.pdf

Older news, may have been posted before...

https://www.clintonhealthaccess.org/early-market-access-vehicle-for-visitect-cd4-advanced-disease-test/